Navigation Links
Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
Date:8/18/2009

r influenza A in North America during this upcoming flu season.

About Naval Medical Research, San Diego

Naval Health Research Center (NHRC) serves as a leading research and development laboratory for the Department of Defense (DoD). NHRC manages and executes expeditionary operational medical research, development and test and evaluation programs for the Naval Medical Research Command, Silver Spring, MD, Navy Medicine Support Command, Jacksonville, FL and the Navy Bureau of Medicine and Surgery (BUMED).

About Adamas

Adamas is an emerging pharmaceutical company focused on developing small molecule, Advantaged Therapeutics(TM) to treat neurological and infectious diseases, including influenza A, the cause of the current flu pandemic. Adamas' approach to pharmaceutical development is to identify synergistic drug mechanisms that can be developed as optimized combination drug therapies to increase safety, efficacy and compliance, thus improving upon the standard of care. Adamas is headquartered in Emeryville, California, with operations in Bangalore, India. For more information about Adamas, please visit www.adamaspharma.com.


'/>"/>
SOURCE Adamas Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Eiger BioPharmaceuticals Announces Initiation of CLEAN-1 HCV Phase 1b Trial
2. Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program
3. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
4. Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
5. Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome
6. BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza
7. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
8. Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center
9. Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
10. Procter & Gamble Pharmaceuticals Launches Asacol(R) HD (mesalamine) Delayed-Release Tablets
11. King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... SHANGHAI , Feb. 27, 2015 WuXi ... capability and technology platform company serving the pharmaceutical, biotechnology, ... China and the United States ... breakthrough therapy designation from the U.S. FDA for ibalizumab ... therapy if it is intended, alone or in combination ...
(Date:2/27/2015)... - La ... monitoraggio dell,infarto congestizio (CHF - Congestive Heart Failure) ...   Vectorious Medical Technologies, società ... il monitoraggio cardiaco destinato a pazienti affetti da ... concluso una raccolta di finanziamenti per 5 milioni ...
(Date:2/27/2015)... , Feb. 27, 2015  Boston Scientific Corporation (NYSE: ... the Barclays 2015 Annual Healthcare Conference on March 10 ... Dan Brennan , executive vice president and chief ... Investor Relations, will participate in a 25-minute question and ... at approximately 1:05 p.m. ET. Following a 5-minute break, ...
Breaking Medicine Technology:WuXi Congratulates TaiMed Biologics on Receiving Breakthrough Therapy Designation from U.S. FDA 2Vectorious Medical Technologies completa una raccolta di 5 milioni di dollari 2Boston Scientific to Participate in the Barclays 2015 Annual Healthcare Conference 2
... May 24, 2007 - Generex ... Dr. Douglas Powell, Director,of Immunobiology ... subsidiary,has presented Antigen's vaccine development ... London, UK. The international meeting,"Developing ...
... 2007 /PRNewswire/ -- With enormous,investments and the ... firms need to develop effective strategies for,communicating ... communication planning and execution will gain a ... research and consulting firm Best Practices, LLC,successful ...
Cached Medicine Technology:Generex Biotechnology Vaccine Strategy Presented at International,Conference in London 2Generex Biotechnology Vaccine Strategy Presented at International,Conference in London 3Clinical Trial Excellence: Shaping Markets Through Early,Communication of Clinical Trial Data 2Clinical Trial Excellence: Shaping Markets Through Early,Communication of Clinical Trial Data 3
(Date:2/28/2015)... March 01, 2015 Heart diseases are ... 10 percent of urban adult population and 5 percent ... heart diseases and 20-30 percent of them require specialized ... ailments and coronary vascular diseases (CVD). , A division ... new market research report titled “Indian Coronary Stent Market ...
(Date:2/28/2015)... The Classic Denture Center , located ... Throughout all of March patients can receive $25 ... service can help overall mouth health and give ... notice certain symptoms that suggest the denture teeth are ... , 1.    Pain, clicking, and popping in the joints, 2.    Pain ...
(Date:2/28/2015)... 28, 2015 A study out of ... gene therapy procedure for the treatment of a hereditary ... Authored by Dr. Robert MacLaren, professor of ... the Lancet Medical Journal on January 16, 2014 , ... rare genetic disorder that mostly affects men and leads ...
(Date:2/28/2015)... 28, 2015 Dr. Perry Patel ... area residents, recently announced a special offer for the ... treatment option for new and established patients at his Pismo ... a bright, white smile, Dr. Patel and his staff ... marked down from the regular price of $450. , ...
(Date:2/28/2015)... On Thursday, February 26th, Forbes published an ... Scammers To Steal Your Data , which stresses the ease ... a DIY phishing kit, or any kind of malware kit ... important point about how everyone’s cyber security is intertwined when ... compromising legitimate content management systems or blogs in order to ...
Breaking Medicine News(10 mins):Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3Health News:Classic Denture Center in Portland Oregon is Offering March Discount 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4
... may have discovered a better way to distinguish acute leukemia ... who need only standard therapy for cure., The study is ... Journal of Medicine with an accompanying editorial. , Researchers say ... cells to help control the kinds and amount of proteins ...
... April 30 Allscripts, the leading,provider of clinical ... improve healthcare, today announced results for the three,months ... ), Total revenue for the three months ... $65.0 million for the same period last year,increasing ...
... FOREST, Ill., April 30 Hospira, Inc.,(NYSE: HSP ... announced that Thomas E. Werner, senior vice president,Finance, and ... Bank of America 2008 Health Care Conference on Wednesday, ... Vegas., The presentation is scheduled to begin at ...
... determine which therapies will benefit certain patients , , ... understanding the extremely fine genetic underpinnings of acute ... which existing therapies will most benefit individual patients. ... physician pick a course of action" using existing ...
... Corporation announces,the launch of a new microsite featuring ... designed to complement Baxa direct sales efforts,and features ... use the site,s interactive tools to explore MedBoard ... frequently asked,questions and key product attributes., "The ...
... Average Prescription Savings of 14-45 ... ... ), one of the nation,s leading pharmacy benefit managers,announced its participation in ... Businesses and the health,care community have rallied around this program to raise ...
Cached Medicine News:Health News:Molecular change may reveal risk of leukemia relapse 2Health News:Molecular change may reveal risk of leukemia relapse 3Health News:Allscripts Reports First Quarter 2008 Results 2Health News:Allscripts Reports First Quarter 2008 Results 3Health News:Allscripts Reports First Quarter 2008 Results 4Health News:Allscripts Reports First Quarter 2008 Results 5Health News:Allscripts Reports First Quarter 2008 Results 6Health News:Allscripts Reports First Quarter 2008 Results 7Health News:Allscripts Reports First Quarter 2008 Results 8Health News:Allscripts Reports First Quarter 2008 Results 9Health News:Allscripts Reports First Quarter 2008 Results 10Health News:Genetic Changes May Dictate Course of Acute Myeloid Leukemia 2Health News:Genetic Changes May Dictate Course of Acute Myeloid Leukemia 3Health News:Baxa Launches Microsite Featuring the MedBoard(TM) Medication Tracking System 2Health News:Medco Joins Cincinnati's 'Cover the Uninsured Week' Effort To Deliver Lower Cost Health Care 2Health News:Medco Joins Cincinnati's 'Cover the Uninsured Week' Effort To Deliver Lower Cost Health Care 3
The Medtronic ULTRAFLEX™ venous cannula provides you with excellent cannula flexibility. This new, unique design provides easy maneuvering during placement and kink resistant flexibility during ...
...
The DLP Elongated One-Piece Arterial Cannulae features a longer body for easier access during conventional and minimally invasive procedures...
... Select CAP® cannulae provides a simple ... readings. An innovative combination of aortic ... line, the Select CAP® can provide ... arterial pressure readings on which you ...
Medicine Products: